Aura Biosciences, Inc. AURA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -95.6%-22.0pp | -73.5%-9.3pp | -64.3%-8.9pp | -55.4%+0.9pp | -56.2%-10.2pp | |
| Return on invested capital | -160.7%-64.2pp | -96.5%-19.7pp | -76.8%+5.0pp | -81.8%-15.4pp | -66.3%-10.4pp | |
| Liquidity | ||||||
| Current ratio | 7.1×-1.1× | 8.1×-0.9× | 9×-3.3× | 12.4×+1.3× | 11.1×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $1.59-29.9% | $2.27-4.5% | $2.38-21.1% | $3.01+17.9% | $2.55-16.6% | |
| Valuation | ||||||
| Market capitalization | $709.23M+89.4% | $346.09M-9.8% | $383.9M-5.5% | $406.13M+38.0% | $294.32M-28.3% | |
| Price / book | 6.6×+3.7× | 2.5×+0.1× | 2.5×+0.1× | 2.3×0.0× | 2.3×-0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Aura Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Aura Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.